UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024375
Receipt number R000028063
Scientific Title The efficacy of new bipolar hemostatic forceps for endoscopic resection
Date of disclosure of the study information 2016/10/13
Last modified on 2017/10/18 16:03:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy of new bipolar hemostatic forceps for endoscopic resection

Acronym

The efficacy of new hemostatic forceps for ER

Scientific Title

The efficacy of new bipolar hemostatic forceps for endoscopic resection

Scientific Title:Acronym

The efficacy of new hemostatic forceps for ER

Region

Japan


Condition

Condition

the gastrointestinal tumor

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To assess the efficasy of new bipolar hemostatic forceps for bleeding during endoscopic resection of the GI tumor

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the successful rate of hemostasis

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

new bipolar hamostatic forceps

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patient for gastrointestinal tumor and subjected to endoscopic resection.

Key exclusion criteria

Patient who judged that we were inappropriate to perform examination safely.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naohisa Yahagi

Organization

Keio University

Division name

Center for Research and Development of Minimally Invasive Treatment, Cancer Center

Zip code


Address

35 Shinanomachi, Shinjyuku-ku, Tokyo

TEL

03-5363-3437

Email

yahagi-tky@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yasutoshi Ochiai

Organization

Keio University

Division name

Center for Research and Development of Minimally Invasive Treatment, Cancer Center

Zip code


Address

35 Shinanomachi, Shinjyuku-ku, Tokyo

TEL

03-5363-3437

Homepage URL


Email

yochiai.a7@keio.jp


Sponsor or person

Institute

Center for Research and Development of Minimally Invasive Treatment, Cancer Center, Keio University

Institute

Department

Personal name



Funding Source

Organization

Center for Research and Development of Minimally Invasive Treatment, Cancer Center, Keio University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 07 Month 22 Day

Date of IRB


Anticipated trial start date

2016 Year 10 Month 13 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 10 Month 12 Day

Last modified on

2017 Year 10 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028063


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name